- Home
- PYPD vs PTN Comparison
PYPD vs PTN Comparison
Compare PYPD & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- PTN
- Stock Information
- Founded
- PYPD 2008
- PTN 1986
- Country
- PYPD Israel
- PTN United States
- Employees
- PYPD N/A
- PTN N/A
- Industry
- PYPD Medical/Dental Instruments
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- PYPD Health Care
- PTN Health Care
- Exchange
- PYPD Nasdaq
- PTN Nasdaq
- Market Cap
- PYPD 24.2M
- PTN 25.4M
- IPO Year
- PYPD 2020
- PTN 1993
- Fundamental
- Price
- PYPD $3.56
- PTN $0.96
- Analyst Decision
- PYPD Strong Buy
- PTN Strong Buy
- Analyst Count
- PYPD 2
- PTN 1
- Target Price
- PYPD $12.00
- PTN $17.00
- AVG Volume (30 Days)
- PYPD 8.1K
- PTN 258.0K
- Earning Date
- PYPD 11-13-2024
- PTN 11-14-2024
- Dividend Yield
- PYPD N/A
- PTN N/A
- EPS Growth
- PYPD N/A
- PTN N/A
- EPS
- PYPD N/A
- PTN N/A
- Revenue
- PYPD N/A
- PTN $2,384,113.00
- Revenue This Year
- PYPD N/A
- PTN N/A
- Revenue Next Year
- PYPD N/A
- PTN N/A
- P/E Ratio
- PYPD N/A
- PTN N/A
- Revenue Growth
- PYPD N/A
- PTN N/A
- 52 Week Low
- PYPD $2.95
- PTN $0.68
- 52 Week High
- PYPD $9.20
- PTN $5.65
- Technical
- Relative Strength Index (RSI)
- PYPD 54.93
- PTN 43.15
- Support Level
- PYPD $3.30
- PTN $1.06
- Resistance Level
- PYPD $3.59
- PTN $1.26
- Average True Range (ATR)
- PYPD 0.21
- PTN 0.14
- MACD
- PYPD 0.02
- PTN -0.01
- Stochastic Oscillator
- PYPD 68.27
- PTN 1.35
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.